Ovid Therapeutics, Inc. (OVID)
1.62
-0.03
(-1.82%)
USD |
NASDAQ |
Feb 27, 15:36
Ovid Therapeutics Research and Development Expense (Quarterly) : 5.853M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cassava Sciences, Inc. | 3.955M |
| PTC Therapeutics, Inc. | 133.13M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.59M |